What is OrthAlign?
OrthAlign is a pioneering medical device firm specializing in computer-assisted surgery technology. Its flagship Lantern platform provides orthopedic surgeons with real-time, data-driven guidance for total hip, total knee, and partial knee arthroplasties. By prioritizing user-friendly, cost-effective, and highly precise instrumentation, the company effectively democratizes access to advanced surgical navigation. This market position allows OrthAlign to serve a diverse range of operating environments, ensuring that high-quality patient outcomes are not limited by the complexity or cost of traditional robotic-assisted systems. The company remains a critical player in the digital health ecosystem, bridging the gap between manual surgical techniques and high-cost robotic platforms.
How much funding has OrthAlign raised?
OrthAlign has raised a total of $37.2M across 5 funding rounds:
Series A
$7.2M
Private Equity
$4M
Series C
$15M
Series D
$10M
Debt
$1M
Series A (2009): $7.2M with participation from Research Corporation
Private Equity (2010): $4M, investors not publicly disclosed
Series C (2014): $15M supported by River Cities Capital Funds and Mutual Capital Partners Funds
Series D (2017): $10M featuring Mutual Capital Partners, Research, River Cities Capital Funds, and California Technology Ventures, LLC
Debt (2020): $1M backed by PPP
Key Investors in OrthAlign
River Cities Capital Funds
RC Capital is a growth equity firm focused on building high-potential healthcare companies by leveraging the interplay of medical devices, healthcare services, and healthcare IT.
Mutual Capital Partners
A Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest, providing both financial support and operational guidance.
California Technology Ventures, LLC
This firm specializes in direct investments in technology and life science companies, focusing on building world-class enterprises through an entrepreneurial and collaborative approach.
What's next for OrthAlign?
With the infusion of $1M, OrthAlign is well-positioned to accelerate its market penetration and expand its technological footprint. The company's strategic roadmap likely involves deepening its R&D efforts to enhance the Lantern platform's capabilities, potentially integrating advanced analytics or expanding into new orthopedic indications. As the healthcare industry shifts toward value-based care, OrthAlign's focus on cost-effective, precise surgical outcomes aligns perfectly with the demands of modern hospital systems. Future growth will likely center on scaling commercial operations, strengthening clinical evidence to support widespread adoption, and leveraging its existing investor network to navigate the complexities of the global medical device market.
See full OrthAlign company page
